Arlington Capital Partners agrees £345.6m takeover of Gooch & Housego

Gooch & Housego PLC (AIM: GHH) has agreed the terms of a recommended cash acquisition by Greenlight Bidco Limited, a newly formed company indirectly owned by Arlington Capital Partners VII, L.P. The offer provides 1,230 pence in cash for each Gooch & Housego share and values the company’s fully diluted equity at approximately £345.6 million. The transaction implies an enterprise value of £400.5 million and values the business at approximately 25.9 times adjusted operating profit for the 12 months ended March 31, 2026. The central tension is clear: shareholders are receiving substantial immediate value, but Arlington Capital Partners must now justify a premium valuation by accelerating growth in a specialised business facing supply-chain, raw-material and programme-delivery constraints.

The acquisition is expected to be implemented through a court-sanctioned scheme of arrangement and has not yet completed. It remains subject to shareholder approval, court sanction and relevant regulatory conditions, with completion currently expected during the fourth quarter of 2026. Gooch & Housego’s directors have unanimously recommended that shareholders vote in favour of the transaction.

How much is Arlington Capital Partners offering for Gooch & Housego shareholders?

Greenlight Bidco Limited is offering 1,230 pence in cash for every Gooch & Housego share. Qualifying investors who were on the shareholder register at the close of business on June 19, 2026 are also entitled to retain the previously declared interim dividend of 4.9 pence per share, taking their total value to 1,234.9 pence. The dividend is scheduled to be paid on July 24, 2026.

That distinction matters for investors purchasing Gooch & Housego shares after the dividend record date. Those buyers are entitled to the 1,230 pence cash consideration if the acquisition completes, but not the additional 4.9 pence dividend. The headline total value of 1,234.9 pence therefore applies only to qualifying shareholders who met the record-date requirement.

The 1,230 pence cash offer represents a 40.7% premium to Gooch & Housego’s closing price of 874 pence on July 15, immediately before the transaction announcement. It also represents premiums of 34% to the one-month volume-weighted average price and 45.7% to the six-month volume-weighted average price. Including the interim dividend, the total value represents a 41.3% premium to the unaffected closing price.

Gooch & Housego’s board did not actively seek a buyer. Arlington Capital Partners made a series of unsolicited proposals, all of which were rejected because the directors believed they did not sufficiently reflect the company’s value and future prospects. The board granted due-diligence access only after Arlington Capital Partners increased its proposal to 1,230 pence per share.

The absence of disclosed values for the earlier proposals prevents investors from measuring exactly how much additional value the board extracted during negotiations. Nevertheless, the sequence shows that the accepted price was not Arlington Capital Partners’ opening position and that Gooch & Housego’s directors were prepared to resist lower approaches.

Why does Arlington Capital Partners want to acquire Gooch & Housego now?

Gooch & Housego designs and manufactures specialised photonic components, optical systems and related technologies for aerospace and defence, industrial and life-sciences customers. Its capabilities include precision optics, thin-film coatings, acousto-optics, electro-optics and fibre-optic systems.

These technologies are used in applications where performance, accuracy and reliability are more important than production volume alone. Gooch & Housego supplies components and systems for imaging, military sighting, armoured-vehicle periscopes, countermeasures, navigation equipment, directed-energy applications, space laser communications, semiconductor processing, industrial lasers and medical diagnostic equipment.

That product positioning makes Gooch & Housego strategically attractive to a private equity investor specialising in regulated and mission-critical markets. Arlington Capital Partners has raised more than US$14 billion of committed capital and focuses on aerospace and defence, government technology, healthcare and specialised business services.

The firm has completed more than 200 transactions over 27 years and owns businesses serving several markets that overlap with Gooch & Housego’s customer base. That experience could provide commercial relationships, acquisition expertise and sector knowledge that a relatively small AIM-listed company may struggle to build independently at the same speed.

The timing is also linked to Gooch & Housego’s improving aerospace and defence performance. Revenue from the segment increased by 51.7% to £35.6 million during the first half of the 2026 financial year, while its adjusted operating margin improved to 10.2%. The company’s order book reached £167.3 million at March 31, up 16.5% on a constant-currency basis from September 2025.

Arlington Capital Partners is therefore buying during a period when the strategic repositioning is producing visible commercial progress, but before the full financial benefits have been converted into higher group margins and cash generation. That creates an opportunity for the buyer, although the high acquisition multiple means much of the expected improvement is already reflected in the purchase price.

Does the 25.9-times operating profit valuation leave Arlington enough upside?

The transaction’s most important financial question is not whether Gooch & Housego is a strong specialist business. The issue is whether its future growth and margin expansion can justify a £400.5 million enterprise value.

The offer represents approximately 25.9 times adjusted operating profit for the 12 months ended March 31, 2026 and around 35.4 times adjusted earnings. Before the offer, Gooch & Housego was valued at approximately 19.4 times adjusted operating profit and 25.2 times adjusted earnings using its July 15 closing price.

Arlington Capital Partners is consequently paying not just for current earnings, but for a substantial portion of the expected benefits from the company’s order book, aerospace and defence momentum, semiconductor recovery and acquisition strategy.

The premium could still produce an attractive outcome if private ownership allows Gooch & Housego to invest more aggressively, improve manufacturing productivity, execute acquisitions and widen margins without the short-term reporting pressure attached to public markets. However, the valuation leaves less room for delayed deliveries, programme changes or margin disappointment.

Gooch & Housego generated £150.5 million of revenue and £11.9 million of adjusted profit before tax during the year ended September 30, 2025. Net debt stood at £43.9 million including lease liabilities, while net debt excluding leases was £29.9 million. In the first half of 2026, revenue increased by 15.5% to £81.9 million and adjusted operating profit rose by 16.9% to £7.2 million.

The adjusted operating margin improved only modestly to 8.8%, which illustrates both the opportunity and the challenge. Arlington Capital Partners is acquiring a business with valuable intellectual property and strong demand, but not yet the consistently high margins that might normally support a valuation approaching 26 times operating profit.

How could private ownership accelerate Gooch & Housego’s acquisition strategy?

Acquisitions have become an important part of Gooch & Housego’s strategy. The company acquired GS Optics in June 2023, Artemis Optical in July 2023, Phoenix Optical Technologies Limited in October 2024 and Global Photonics in June 2025. These transactions expanded its precision-optics, optical-systems and thin-film coating capabilities, particularly in the United States.

The acquired businesses are now largely integrated and have helped Gooch & Housego win new defence orders from customers in the United States, United Kingdom and Europe. The company also sold EM4 in March 2024 as part of its portfolio repositioning.

Private ownership could allow Gooch & Housego to pursue larger or more frequent acquisitions without repeatedly seeking support from public shareholders. Arlington Capital Partners has indicated that additional capital could be used to accelerate both organic investment and selective mergers and acquisitions.

That flexibility is potentially valuable because the photonics market remains fragmented. Many businesses possess specialised technologies, customer approvals or manufacturing capabilities that could become more valuable when combined with Gooch & Housego’s wider commercial platform.

The risk is that faster acquisition activity could produce higher debt, integration complexity and pressure on management resources. Gooch & Housego has already completed several transactions within a relatively short period. Arlington Capital Partners must avoid turning a technically focused business into a collection of loosely connected assets.

The strongest outcome would come from acquiring capabilities that deepen existing customer relationships, increase system content and improve margins. Acquisitions pursued mainly to add revenue would be less likely to justify the premium paid for the company.

Why is aerospace and defence becoming more important to Gooch & Housego’s growth?

Aerospace and defence generated £52.4 million of Gooch & Housego’s revenue during the 2025 financial year, compared with £64.3 million from industrial customers and £33.7 million from life sciences. The defence segment was not the largest division at that point, but it became the company’s fastest-growing business during the first half of 2026.

Demand is being supported by higher defence budgets, increased procurement of surveillance and navigation systems, investment in countermeasure technologies and the development of directed-energy and space-based communications capabilities.

Gooch & Housego’s opportunity is not limited to supplying a single platform or weapons programme. Its technologies can be used across land, air, sea and space applications, allowing the company to participate in multiple procurement cycles.

The acquisition of Global Photonics also established a broader optical-systems capability in the United States, where proximity to defence customers and prime contractors can be commercially important. Local manufacturing is becoming more valuable as governments place greater emphasis on secure supply chains, domestic capacity and resilience.

Arlington Capital Partners’ sector relationships could help Gooch & Housego gain earlier visibility into customer requirements and participate in larger programmes. However, defence orders typically involve long qualification cycles, demanding technical standards and uncertain programme timing. A strong order book does not automatically convert into revenue on a predictable quarterly schedule.

What operating risks remain behind Gooch & Housego’s record order book?

Gooch & Housego entered the takeover process with a record £167.3 million order book, giving the company substantial revenue visibility. Management nevertheless warned that the 2026 financial year would be more heavily weighted towards the fourth quarter because supply-chain constraints had affected the timing of deliveries and order conversion.

This is the principal operational tension behind the acquisition. Demand appears strong, particularly in aerospace and defence, but the company must obtain specialised materials, remove manufacturing bottlenecks and deliver technically complex products on customer schedules.

Germanium is one important pressure point. The material is used in aerospace, defence and semiconductor applications, but its price has increased substantially and availability remains constrained. Gooch & Housego has diversified some sources and maintained higher inventories, yet its relative scale makes it harder to absorb sudden cost increases within short reporting periods.

Industrial revenue was flat at £30.3 million during the first half of 2026, although order intake improved as semiconductor-related demand began recovering. Life-sciences revenue fell by 7.7% to £16 million, while the division’s adjusted operating margin declined to 4.6%.

The portfolio therefore contains businesses moving at different speeds. Aerospace and defence is expanding rapidly, industrial demand is recovering, and life sciences remains weaker. Arlington Capital Partners will need to improve the lower-performing operations without distracting management from the defence opportunity.

What could Arlington Capital Partners change after the acquisition completes?

Arlington Capital Partners intends to conduct a detailed review of Gooch & Housego during the first six months after completion. The evaluation will examine business lines, acquisition opportunities, research and development, capital spending, manufacturing, the global supply chain and potential measures to improve profitability.

Gooch & Housego is expected to continue operating as a standalone business group, while its headquarters will remain in Ilminster, Somerset. Arlington Capital Partners has also indicated that it does not intend to reduce investment in research and development, although manufacturing allocation and facility investment may be reviewed.

The buyer plans to reorganise Gooch & Housego’s corporate structure by placing its United States operations beneath a subgroup owned by United States legal entities. The change is not expected to alter day-to-day operational management or employee functions, but it reflects the strategic importance of the company’s American defence and industrial platform.

Some workforce changes are expected. Public-company and back-office positions that are no longer required after delisting may be removed, while Gooch & Housego already plans headcount reductions linked to its exit from the medical laser Pockels Cells manufacturing business in Cleveland, Ohio.

Arlington Capital Partners has said it does not intend to make material reductions to the group’s overall workforce. Nevertheless, additional changes could follow the six-month evaluation depending on its conclusions. The bidder’s statements therefore indicate targeted restructuring rather than a commitment to preserve every existing role.

Why did Gooch & Housego shares stop below the 1,230p cash offer price?

Gooch & Housego shares closed at approximately 1,210 pence on July 16, up 38.4% from the previous closing price of 874 pence. The shares traded as high as 1,270 pence during the session before settling below the 1,230 pence cash consideration.

The closing price left a spread of around 20 pence to the cash offer, equivalent to approximately 1.7%. That discount reflects the time required to complete the acquisition, the remaining shareholder and court approvals and the possibility that conditions are not satisfied.

The trading pattern is complicated by the interim dividend. Investors purchasing shares after the June 19 record date are not entitled to the 4.9 pence payment, meaning the economically relevant offer value for new buyers is 1,230 pence rather than 1,234.9 pence.

The shares were about 46% above their July 9 closing price of 826 pence and had moved beyond the previous 52-week high of 1,115 pence. The 52-week low before the acquisition announcement was 463.1 pence.

The narrow remaining spread suggests the market assigns a relatively high probability to completion. It does not eliminate transaction risk, particularly because the timetable extends into the fourth quarter and the scheme still requires formal approvals.

What approvals are required before the Gooch & Housego acquisition can complete?

The transaction requires approval from a majority in number of voting scheme shareholders who represent at least 75% of the value voted at the court meeting. Shareholders must also approve the related resolutions at a general meeting.

After shareholder approval and satisfaction or waiver of the remaining conditions, the scheme must be sanctioned by the court. A copy of the court order must then be delivered to the Registrar of Companies before the acquisition becomes effective.

The cash consideration will be financed through equity invested by Arlington Capital Partners. J.P. Morgan Cazenove has confirmed that sufficient resources are available to Greenlight Bidco Limited to fund the consideration. Financing risk therefore appears more limited than the execution and approval risks normally attached to a pending takeover.

Directors holding approximately 0.44% of Gooch & Housego’s existing shares have provided irrevocable undertakings to support the transaction. Those commitments remain binding even if a higher competing offer is announced, although the small percentage means the wider shareholder vote remains decisive.

Once the scheme becomes effective, Gooch & Housego’s admission to trading on AIM will be cancelled and the business is expected to be re-registered as a private company.

What does the takeover reveal about the valuation of British specialist manufacturers?

The Gooch & Housego acquisition continues a pattern in which overseas buyers target British-listed engineering and technology businesses with specialised capabilities, international customers and relatively modest public-market valuations.

The company’s share price had already recovered strongly before the approach, reaching a previous 52-week high of 1,115 pence in June. Arlington Capital Partners still needed to offer a substantial premium to secure the board’s recommendation.

This is therefore not simply a case of a buyer acquiring a neglected company at a bargain price. The 25.9-times adjusted operating profit multiple shows that Arlington Capital Partners is paying for strategic scarcity, defence exposure and anticipated margin improvement.

The broader public-market question is whether a smaller AIM-listed company can access sufficient capital, acquisition flexibility and executive incentives to compete with larger international peers. Gooch & Housego’s board concluded that shareholders should accept immediate cash value rather than carry the operational and market risks involved in delivering the independent strategy.

For Arlington Capital Partners, the next test begins only after ownership changes. The buyer must convert Gooch & Housego’s order book into revenue, strengthen margins, protect specialist talent and use additional capital without weakening financial discipline. Successful execution could validate the premium. Delayed programmes, continued supply disruption or poorly integrated acquisitions would make the 25.9-times valuation considerably harder to defend.

Key takeaways from Arlington Capital Partners’ recommended acquisition of Gooch & Housego

• Greenlight Bidco Limited, indirectly owned by Arlington Capital Partners VII, L.P., has offered 1,230 pence in cash for each Gooch & Housego share.
• The cash consideration values Gooch & Housego’s fully diluted equity at approximately £345.6 million and implies an enterprise value of £400.5 million.
• Qualifying shareholders registered on June 19, 2026 may retain the 4.9 pence interim dividend, taking their total value to 1,234.9 pence per share.
• The cash offer represents a 40.7% premium to Gooch & Housego’s unaffected closing price of 874 pence on July 15.
• Arlington Capital Partners is paying approximately 25.9 times trailing adjusted operating profit, creating a demanding benchmark for future growth and margin delivery.
• Gooch & Housego’s aerospace and defence revenue increased by 51.7% during the first half of 2026, while its order book reached £167.3 million.
• Supply-chain constraints, germanium availability and delayed order conversion remain the most important near-term operating risks.
• Arlington Capital Partners intends to complete a six-month strategic and operational evaluation after the acquisition becomes effective.
• Some public-company and back-office positions are expected to be removed, although the bidder does not currently anticipate material group-wide headcount reductions.
• The acquisition remains conditional and is expected to complete during the fourth quarter of 2026 following shareholder, court and regulatory approvals.